171 related articles for article (PubMed ID: 37572191)
1. 3D fusion is superior to 2D point-to-point contrast-enhanced US to evaluate the ablative margin after RFA for hepatocellular carcinoma.
Long H; Zhou X; Zhang X; Ye J; Huang T; Cong L; Xie X; Huang G
Eur Radiol; 2024 Feb; 34(2):1247-1257. PubMed ID: 37572191
[TBL] [Abstract][Full Text] [Related]
2. Contrast-enhanced ultrasonography-CT/MRI fusion guidance for percutaneous ablation of inconspicuous, small liver tumors: improving feasibility and therapeutic outcome.
Lee Y; Yoon JH; Han S; Joo I; Lee JM
Cancer Imaging; 2024 Jan; 24(1):4. PubMed ID: 38172949
[TBL] [Abstract][Full Text] [Related]
3. Assessment of radiofrequency ablation margin by MRI-MRI image fusion in hepatocellular carcinoma.
Wang XL; Li K; Su ZZ; Huang ZP; Wang P; Zheng RQ
World J Gastroenterol; 2015 May; 21(17):5345-51. PubMed ID: 25954109
[TBL] [Abstract][Full Text] [Related]
4. Three-dimensional ultrasound fusion imaging in precise needle placement for thermal ablation of hepatocellular carcinoma.
Liu J; Guo Y; Sun Y; Liu M; Zhang X; Zheng R; Cong L; Liu B; Xie X; Huang G
Int J Hyperthermia; 2024; 41(1):2316097. PubMed ID: 38360570
[TBL] [Abstract][Full Text] [Related]
5. Dynamic Three-Dimensional Contrast-Enhanced Ultrasound to Predict Therapeutic Response of Radiofrequency Ablation in Hepatocellular Carcinoma: Preliminary Findings.
Cao J; Dong Y; Mao F; Wang W
Biomed Res Int; 2018; 2018():6469703. PubMed ID: 30225261
[TBL] [Abstract][Full Text] [Related]
6. Ablative safety margin depicted by fusion imaging with post-treatment contrast-enhanced ultrasound and pre-treatment CECT/CEMRI after radiofrequency ablation for liver cancers.
Bo XW; Xu HX; Guo LH; Sun LP; Li XL; Zhao CK; He YP; Liu BJ; Li DD; Zhang K; Wang D
Br J Radiol; 2017 Oct; 90(1078):20170063. PubMed ID: 28749166
[TBL] [Abstract][Full Text] [Related]
7. No-Touch Radiofrequency Ablation Using Twin Cooled Wet Electrodes for Recurrent Hepatocellular Carcinoma Following Locoregional Treatments.
Hong SJ; Kim JH; Yoon JH; Park JH; Yoon JH; Kim YJ; Yu SJ; Cho EJ; Lee JM
Korean J Radiol; 2024 May; 25(5):438-448. PubMed ID: 38685734
[TBL] [Abstract][Full Text] [Related]
8. Three-dimensional contrast-enhanced ultrasound fusion imaging predicts local tumor progression by evaluating ablative margin of radiofrequency ablation for hepatocellular carcinoma: a preliminary report.
Ye J; Huang G; Zhang X; Xu M; Zhou X; Lin M; Xie X; Xie X
Int J Hyperthermia; 2019; 36(1):55-64. PubMed ID: 30444428
[TBL] [Abstract][Full Text] [Related]
9. LI-RADS category is associated with treatment outcomes of small single HCC: surgical resection vs. radiofrequency ablation.
Min JH; Lee MW; Rhim H; Han S; Song KD; Kang TW; Jeong WK; Cha DI; Kim JM; Choi GS; Kim K
Eur Radiol; 2024 Jan; 34(1):525-537. PubMed ID: 37526668
[TBL] [Abstract][Full Text] [Related]
10. A feasibility study for determining ablative margin with 3D-CEUS-CT/MR image fusion after radiofrequency ablation of hepatocellular carcinoma.
Zhong-Zhen S; Kai L; Rong-Qin Z; Er-Jiao X; Ting Z; Ao-Hua Z; Shu-Fang Y; Xu-Qi H
Ultraschall Med; 2012 Dec; 33(7):E250-E255. PubMed ID: 23238803
[TBL] [Abstract][Full Text] [Related]
11. The tumor ghost on MRI after microwave ablation for hepatocellular carcinoma: A new modality to assess the ablative margin.
Liu S; Wu J; Ding W; Zhang C; Luo Y; Bai X; Wen K; Han Z; Yu J; Liang P
Eur J Radiol; 2023 Jan; 158():110617. PubMed ID: 36463706
[TBL] [Abstract][Full Text] [Related]
12. Percutaneous Radiofrequency Ablation of Small (1-2 cm) Hepatocellular Carcinomas Inconspicuous on B-Mode Ultrasonographic Imaging: Usefulness of Combined Fusion Imaging with MRI and Contrast-Enhanced Ultrasonography.
Lee MW; Lim HK; Rhim H; Cha DI; Kang TW; Song KD; Min JH; Gwak GY; Kim S; Lu DSK
Can J Gastroenterol Hepatol; 2018; 2018():7926923. PubMed ID: 30013957
[TBL] [Abstract][Full Text] [Related]
13. Safety margin after radiofrequency ablation of hepatocellular carcinoma: precise assessment with a three-dimensional reconstruction technique using CT imaging.
Jiang C; Liu B; Chen S; Peng Z; Xie X; Kuang M
Int J Hyperthermia; 2018 Dec; 34(8):1135-1141. PubMed ID: 29392978
[TBL] [Abstract][Full Text] [Related]
14. Improvement of ablative margins by the intraoperative use of CEUS-CT/MR image fusion in hepatocellular carcinoma.
Li K; Su ZZ; Xu EJ; Ju JX; Meng XC; Zheng RQ
BMC Cancer; 2016 Apr; 16():277. PubMed ID: 27090513
[TBL] [Abstract][Full Text] [Related]
15. Use of intra-procedural fusion imaging combining contrast-enhanced ultrasound using a perflubutane-based contrast agent and auto sweep three-dimensional ultrasound for guiding radiofrequency ablation and evaluating its efficacy in patients with hepatocellular carcinoma.
Sanga K; Numata K; Nihonmatsu H; Ogushi K; Fukuda H; Chuma M; Hashimoto H; Koizumi N; Maeda S
Int J Hyperthermia; 2020; 37(1):202-211. PubMed ID: 32070164
[No Abstract] [Full Text] [Related]
16. Predictive Value of Ablative Margin Assessment After Microwave Ablation for Local Tumor Progression in Medium and Large Hepatocellular Carcinoma: Computed Tomography-Computed Tomography Image Fusion Method Versus Side-by-Side Method.
Zhou H; Yang G; Jing X; Zhou Y; Ding J; Wang Y; Wang F; Zhao L
J Comput Assist Tomogr; 2023 Jan-Feb 01; 47(1):31-37. PubMed ID: 36668979
[TBL] [Abstract][Full Text] [Related]
17. Fusion imaging techniques and contrast-enhanced ultrasound for thermal ablation of hepatocellular carcinoma - A prospective randomized controlled trial.
Huang Q; Zeng Q; Long Y; Tan L; Zheng R; Xu E; Li K
Int J Hyperthermia; 2019; 36(1):1207-1215. PubMed ID: 31813295
[No Abstract] [Full Text] [Related]
18. Evaluation of the ablation margin of hepatocellular carcinoma using CEUS-CT/MR image fusion in a phantom model and in patients.
Li K; Su Z; Xu E; Huang Q; Zeng Q; Zheng R
BMC Cancer; 2017 Jan; 17(1):61. PubMed ID: 28103837
[TBL] [Abstract][Full Text] [Related]
19. 3-D Contrast-Enhanced Ultrasound Fusion Imaging: A New Technique to Evaluate the Ablative Margin of Radiofrequency Ablation for Hepatocellular Carcinoma.
Zhang X; Huang G; Ye J; Xu M; Cong L; He X; Huang T; Kuang M; Xie X
Ultrasound Med Biol; 2019 Aug; 45(8):1933-1943. PubMed ID: 31109841
[TBL] [Abstract][Full Text] [Related]
20. Fusion imaging-guided radiofrequency ablation with artificial ascites or pleural effusion in patients with hepatocellular carcinomas: the feasibility rate and mid-term outcome.
Kim JH; Lee JY; Yu SJ; Lee DH; Joo I; Yoon JH; Kim YJ; Yoon JH; Lee JM
Int J Hyperthermia; 2023; 40(1):2213424. PubMed ID: 37253458
[No Abstract] [Full Text] [Related]
[Next] [New Search]